Literature DB >> 26980624

Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.

Zobair Younossi1, Linda Henry2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) are common causes of chronic liver disease. NAFLD is associated with obesity and metabolic syndrome whereas ALD is associated with excessive alcohol consumption. Both diseases can progress to cirrhosis, hepatocellular carcinoma, and liver-related death. A higher proportion of patients with NAFLD die from cardiovascular disorders than patients with ALD, whereas a higher proportion of patients with ALD die from liver disease. NAFLD and ALD each are associated with significant morbidity, impairment to health-related quality of life, and economic costs to society.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALD; Mortality; NAFLD

Mesh:

Year:  2016        PMID: 26980624     DOI: 10.1053/j.gastro.2016.03.005

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  85 in total

Review 1.  Hepatocellular carcinoma and non-alcoholic fatty liver disease.

Authors:  Pegah Golabi; Logan Rhea; Linda Henry; Zobair M Younossi
Journal:  Hepatol Int       Date:  2019-11-07       Impact factor: 6.047

2.  Oncogene UBE2I enhances cellular invasion, migration and proliferation abilities via autophagy-related pathway resulting in poor prognosis in hepatocellular carcinoma.

Authors:  Xiang-Kun Wang; Xi-Wen Liao; Xin Zhou; Chuang-Ye Han; Zi-Jun Chen; Cheng-Kun Yang; Jian-Lu Huang; Jian-Yao Wang; Jun-Qi Liu; Hua-Sheng Huang; Shu-Tian Mo; Xin-Ping Ye; Guang-Zhi Zhu; Tao Peng
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

3.  ChREBP refines the hepatic response to fructose to protect the liver from injury.

Authors:  Angela M Hall; Brian N Finck
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

4.  Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance?

Authors:  Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2017-07-04

Review 5.  The Stomach as an Endocrine Organ: Expression of Key Modulatory Genes and Their Contribution to Obesity and Non-alcoholic Fatty Liver Disease (NAFLD).

Authors:  Aybike Birerdinc; Sasha Stoddard; Zobair M Younossi
Journal:  Curr Gastroenterol Rep       Date:  2018-04-19

6.  Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA.

Authors:  Eliza W Beal; Dmitry Tumin; Ali Kabir; Dimitrios Moris; Xu-Feng Zhang; Jeffery Chakedis; Kenneth Washburn; Sylvester Black; Carl M Schmidt; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

Review 7.  Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.

Authors:  Thomas Greuter; Harmeet Malhi; Gregory J Gores; Vijay H Shah
Journal:  JCI Insight       Date:  2017-09-07

8.  Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.

Authors:  Arun J Sanyal; Philippe Mathurin; Laura A Nagy
Journal:  Gastroenterology       Date:  2016-05-04       Impact factor: 22.682

Review 9.  Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease.

Authors:  Iraklis Perysinakis; Harilaos C Pappis; Elias Margaris
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

10.  Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Shanshan Jin; Suwen Jiang; Airong Hu
Journal:  Sleep Breath       Date:  2018-01-15       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.